Reversal of nonarteritic anterior ischemic optic neuropathy associated with coexisting primary antiphospholipid syndrome and Factor V Leiden mutation

American Journal of Ophthalmology

Volumn 131, Issue 5, 2001, Pages 671-673

  Srinivasan, Sathish ^a,b   Fern, Alistair ^a   Watson, W H ^a   McColl, Mark D ^a  

^a MONKLANDS HOSPITAL   (United Kingdom)

^b NONE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; LOW MOLECULAR WEIGHT HEPARIN; TINZAPARIN; WARFARIN;

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CASE REPORT; FEMALE; FLUORESCENCE ANGIOGRAPHY; GENE MUTATION; HUMAN; ISCHEMIC OPTIC NEUROPATHY; PRIORITY JOURNAL; VISUAL DISORDER;

ACTIVATED PROTEIN C RESISTANCE; ANTICOAGULANTS; ANTIPHOSPHOLIPID SYNDROME; ARTERITIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FACTOR V; FEMALE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; MIDDLE AGED; OPTIC NEUROPATHY, ISCHEMIC; POINT MUTATION; POLYMERASE CHAIN REACTION; WARFARIN;

EID: 0035021341     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(00)00873-4     Document Type: Article

References (5)

1. Brenner B, Vulfsons SL, Lanir N, et al. Coexistence of familial antiphospholipid syndrome and factor V Leiden: impact on thrombotic diathesis. Br J Haematol 1996;94:167.
2. McColl MD, Chalmers EA, Thomas. A, et al. Factor V Leiden, prothrombin 20210G-A and MTHFR C677T mutations in childhood stroke. Thrombosis and Haemostasis 1999;81:690-4.
3. Rosendaal FR, Siscovick DS, Schwartz SM, et al. Factor V Leiden (resistance to activated protein C) increases the risk of myocardial infarction in young women. Blood 1997;89:2817-2821.
4. Hayreh SS. The Von Sallman Lecture. The optic nerve head circulation in health disease. Exp Eye Res 1995;61:259-272.
5. Acheson JF, Sanders MD. Coagulation abnormalities in ischaemic optic neuropathy. Eye 1994;8:89-92.